Skip to main content

Table 2 Lipid profile in the SLE subjects and the control

From: Dysregulated serum lipid profile and its correlation to disease activity in young female adults diagnosed with systemic lupus erythematosus: a cross-sectional study

ParameterSLE (n = 71)Control (n = 71)ReferenceP
Total cholesterol (TC, mmol/L)3.10 ± 0.08*4.27 ± 0.103.10~5.690.02
Triglyceride (TG, mmol/L)2.22 ± 0.06*0.82 ± 0.030.40~1.60< 0.01
HDL-C (mmol/L)0.83 ± 0.04*1.56 ± 0.050.83~1.960.02
LDL-C (mmol/L)1.68 ± 0.05*2.53 ± 0.042.07~3.10< 0.01
VLDL-C (mmol/L)0.78 ± 0.03*0.28 ± 0.020.08~0.41< 0.01
Apolipoprotein A (Apo A, g/L)0.88 ± 0.03*1.32 ± 0.041.00~2.00< 0.01
Apolipoprotein B (Apo B, g/L)0.63 ± 0.02*0.92 ± 0.040.60~1.100.03
Apolipoprotein E (Apo E, mg/L)38.57 ± 1.2936.62 ± 1.1427.00~45.000.08
  1. HDL-C High-density lipoprotein-cholesterol, LDL-C Low-density lipoprotein-cholesterol, VLDL-C Very low-density lipoprotein-cholesterol, and Data are mean ± SEM. Statistically significant difference between the SLE subjects and the control (*P < 0.05)